[Federal Register Volume 67, Number 183 (Friday, September 20, 2002)]
[Notices]
[Page 59271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23853]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Method for Detecting 
Clostridium Botulinum Neurotoxin Serotypes, A, B, E and F in a Sample

AGENCY: Department of the Army, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
09/952,078 entitled ``Method for Detecting Clostridium Botulinum 
Neurotoxin Serotypes A, B, E and F in a Sample,'' filed September 14, 
2001. Foreign rights (PCT/US01/28641) are also available. The United 
States Government, as represented by the Secretary of the Army has 
rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Sensitive and specific enzyme-linked 
immunosorbent assays which detect Clostridium botulinum neurotoxins 
serotypes A, B, E, and F in a sample are described. The assay is based 
upon affinity-purified antibodies directed against the C-fragments of 
each toxin. These assays demonstrate sensitivity close to that of the 
mouse bioassay without the use of animals and in a much simpler format 
than other assays of similar sensitivity.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-23853 Filed 9-19-02; 8:45 am]
BILLING CODE 3710-08-M